Maryland SB124 mandates labeling for gene structure- and function-modifying products sold in the state.
Maryland SB124 introduces regulations for gene structure- and function-modifying products, requiring sellers to label these products with specific information. The bill defines "modern biotechnology methods" to include gene editing, RNA interference, and transgenesis. It mandates that any product designed to alter gene structure or function must be labeled with the phrase "gene structure- or function-modifying product" and all potential risks, side effects, and adverse effects. Violations of this labeling requirement are subject to criminal and civil penalties.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.